The synthesis of endogenous glutathione occurs in a tightly regulated, two-step enzymatic process
reported in approximately 4060% of participants in higher-dose groups [1] Vomiting reported in approximately 2030% of participants at higher doses Diarrhoea Constipation Decreased appetite (which, whilst contributing to weight loss, can also be uncomfortable) The majority of gastrointestinal events were mild to moderate in severity and tended to diminish over time as participants adjusted to the medication
Vukojevic et al., 2020), appears as the specific effect of BPC 157 in ischemia/reperfusion (Vukojevic et al., 2018
Hyperglycemia and RAAS in the Kidney High glucose levels in the proximal tubule can cause increased reabsorption of glucose, sodium and water, favored by the upregulation of SGLT2 activity and expression of Na-K-2Cl cotransporter, acquaporin-2, and urea transporters, as reported in diabetic patients (32)